MedPath

Probiotics in Eczema

Not Applicable
Conditions
Health Condition 1: L209- Atopic dermatitis, unspecified
Registration Number
CTRI/2022/07/044171
Lead Sponsor
RESEARCH CELL ALL INDIA INSTITUTE OF MEDICAL SCIENCES JODHPUR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Clinically diagnosed cases of atopic dermatitis (U.K. Working Party diagnostic criteria)

Patient with SCORAD of <50

Patients whose parents or legal representative signed the written informed consent

Treatment wash off period of atleast 2 months for systemic corticosteroids and immunosuppressants

Exclusion Criteria

Patient with chronic underlying disease (uncontrolled diabetes mellitus, uncontrolled hypertension, active tuberculosis) or is on immunosuppressive therapy.

Children with severe hepatic, renal or other systemic disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Change in SCORAD <br/ ><br>Timepoint: 1. Change in SCORAD at 0 and 12 week <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1. IL-31 level value change <br/ ><br>2. Number of replapses <br/ ><br>3. Adverse event if anyTimepoint: 1. IL-31 at 0 and 12 week <br/ ><br>2. Relapses - Need for topical corticosteroid therapy with duration in follow up <br/ ><br>3. Adverse event at each visit <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath